ArticleRMD open2023

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Christina Charles-Schoeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.